Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17454059rdf:typepubmed:Citationlld:pubmed
pubmed-article:17454059lifeskim:mentionsumls-concept:C0038317lld:lifeskim
pubmed-article:17454059lifeskim:mentionsumls-concept:C0162969lld:lifeskim
pubmed-article:17454059lifeskim:mentionsumls-concept:C1521970lld:lifeskim
pubmed-article:17454059lifeskim:mentionsumls-concept:C0011209lld:lifeskim
pubmed-article:17454059lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:17454059lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:17454059lifeskim:mentionsumls-concept:C0524527lld:lifeskim
pubmed-article:17454059lifeskim:mentionsumls-concept:C0439828lld:lifeskim
pubmed-article:17454059pubmed:issue3lld:pubmed
pubmed-article:17454059pubmed:dateCreated2007-4-24lld:pubmed
pubmed-article:17454059pubmed:abstractTextChitosan film formulations for steroid delivery after craniomaxillofacial surgery were formulated by using three different types of chitosan with respect to their molecular weight as low, medium and high. Film formulations were prepared by casting/solvent evaporation technique. In vitro characterization, film thickness, equilibrium swelling degree, in vitro release profiles and surface morphologies were investigated. For two different types of crosslinkings, the release of dexamethasone sodium phosphate (DSP) can be extended as the molecular weight increases. As a result, chitosan film formulations should be beneficial for steroid delivery for a certain time after craniomaxillofacial surgery.lld:pubmed
pubmed-article:17454059pubmed:languageenglld:pubmed
pubmed-article:17454059pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17454059pubmed:citationSubsetIMlld:pubmed
pubmed-article:17454059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17454059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17454059pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17454059pubmed:statusMEDLINElld:pubmed
pubmed-article:17454059pubmed:monthMarlld:pubmed
pubmed-article:17454059pubmed:issn0363-9045lld:pubmed
pubmed-article:17454059pubmed:authorpubmed-author:SargonMustafa...lld:pubmed
pubmed-article:17454059pubmed:authorpubmed-author:OnerLeventLlld:pubmed
pubmed-article:17454059pubmed:authorpubmed-author:Ero?luHakanHlld:pubmed
pubmed-article:17454059pubmed:issnTypePrintlld:pubmed
pubmed-article:17454059pubmed:volume33lld:pubmed
pubmed-article:17454059pubmed:ownerNLMlld:pubmed
pubmed-article:17454059pubmed:authorsCompleteYlld:pubmed
pubmed-article:17454059pubmed:pagination265-71lld:pubmed
pubmed-article:17454059pubmed:meshHeadingpubmed-meshheading:17454059...lld:pubmed
pubmed-article:17454059pubmed:meshHeadingpubmed-meshheading:17454059...lld:pubmed
pubmed-article:17454059pubmed:meshHeadingpubmed-meshheading:17454059...lld:pubmed
pubmed-article:17454059pubmed:meshHeadingpubmed-meshheading:17454059...lld:pubmed
pubmed-article:17454059pubmed:meshHeadingpubmed-meshheading:17454059...lld:pubmed
pubmed-article:17454059pubmed:meshHeadingpubmed-meshheading:17454059...lld:pubmed
pubmed-article:17454059pubmed:year2007lld:pubmed
pubmed-article:17454059pubmed:articleTitleChitosan formulations for steroid delivery: effect of formulation variables on in vitro characteristics.lld:pubmed
pubmed-article:17454059pubmed:affiliationDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.lld:pubmed
pubmed-article:17454059pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17454059pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed